Update on the optimal use of voriconazole for invasive fungal infections

Asma Lat, George R. Thompson

Resultado de la investigación: Review articlerevisión exhaustiva

65 Citas (Scopus)


Voriconazole is an extended-spectrum triazole with excellent bioavailability that has now become the treatment of choice for aspergillosis. It has a unique side effect profile compared with other azoles, as well as a number of clinically important drug-drug interactions. These factors, along with a correlation between increased serum levels and improved outcomes, have prompted an interest in therapeutic drug monitoring of this agent. The pharmacology and clinical outcomes data of voriconazole are presented in this review.

Idioma originalEnglish (US)
Páginas (desde-hasta)43-53
Número de páginas11
PublicaciónInfection and Drug Resistance
EstadoPublished - 2011
Publicado de forma externa

ASJC Scopus subject areas

  • Pharmacology
  • Infectious Diseases
  • Pharmacology (medical)


Profundice en los temas de investigación de 'Update on the optimal use of voriconazole for invasive fungal infections'. En conjunto forman una huella única.

Citar esto